Logo image of CTRI

CENTURI HOLDINGS INC (CTRI) Stock Fundamental Analysis

NYSE:CTRI - New York Stock Exchange, Inc. - US1559231055 - Common Stock - Currency: USD

18.63  -1.06 (-5.38%)

After market: 18.63 0 (0%)

Fundamental Rating

2

Taking everything into account, CTRI scores 2 out of 10 in our fundamental rating. CTRI was compared to 49 industry peers in the Construction & Engineering industry. CTRI may be in some trouble as it scores bad on both profitability and health. CTRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTRI has reported negative net income.
CTRI Yearly Net Income VS EBIT VS OCF VS FCFCTRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.81%, CTRI is doing worse than 86.96% of the companies in the same industry.
With a Return On Equity value of -35.31%, CTRI is not doing good in the industry: 84.78% of the companies in the same industry are doing better.
The Return On Invested Capital of CTRI (6.21%) is comparable to the rest of the industry.
CTRI had an Average Return On Invested Capital over the past 3 years of 4.00%. This is significantly below the industry average of 11.92%.
The 3 year average ROIC (4.00%) for CTRI is below the current ROIC(6.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.81%
ROE -35.31%
ROIC 6.21%
ROA(3y)-4.59%
ROA(5y)N/A
ROE(3y)-39.14%
ROE(5y)N/A
ROIC(3y)4%
ROIC(5y)N/A
CTRI Yearly ROA, ROE, ROICCTRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

With a Operating Margin value of 4.71%, CTRI perfoms like the industry average, outperforming 45.65% of the companies in the same industry.
CTRI has a Gross Margin of 9.43%. This is in the lower half of the industry: CTRI underperforms 71.74% of its industry peers.
Industry RankSector Rank
OM 4.71%
PM (TTM) N/A
GM 9.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTRI Yearly Profit, Operating, Gross MarginsCTRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 5 -5

More info and screens

3

2. Health

2.1 Basic Checks

CTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CTRI remains at a similar level compared to 1 year ago.
The debt/assets ratio for CTRI is higher compared to a year ago.
CTRI Yearly Shares OutstandingCTRI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M
CTRI Yearly Total Debt VS Total AssetsCTRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.24 indicates that CTRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRI has a Altman-Z score of 2.24. This is comparable to the rest of the industry: CTRI outperforms 41.30% of its industry peers.
CTRI has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
CTRI has a worse Debt to Equity ratio (1.72) than 80.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACC0.6
WACC10.39%
CTRI Yearly LT Debt VS Equity VS FCFCTRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

CTRI has a Current Ratio of 1.64. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a better Current ratio (1.64) than 67.39% of its industry peers.
CTRI has a Quick Ratio of 1.64. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a better Quick ratio (1.64) than 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
CTRI Yearly Current Assets VS Current LiabilitesCTRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

CTRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.72%.
CTRI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.03%.
EPS 1Y (TTM)-10.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 34.69% on average over the next years. This is a very strong growth
Based on estimates for the next years, CTRI will show a small growth in Revenue. The Revenue will grow by 0.26% on average per year.
EPS Next Y113.5%
EPS Next 2Y52.36%
EPS Next 3Y34.69%
EPS Next 5YN/A
Revenue Next Year-8.7%
Revenue Next 2Y-2.36%
Revenue Next 3Y0.26%
Revenue Next 5YN/A

3.3 Evolution

CTRI Yearly Revenue VS EstimatesCTRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
CTRI Yearly EPS VS EstimatesCTRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CTRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 26.97 indicates a quite expensive valuation of CTRI.
Based on the Price/Forward Earnings ratio, CTRI is valued a bit more expensive than the industry average as 63.04% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of CTRI to the average of the S&P500 Index (22.68), we can say CTRI is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 26.97
CTRI Price Earnings VS Forward Price EarningsCTRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

CTRI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTRI is cheaper than 91.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.98
CTRI Per share dataCTRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRI's earnings are expected to grow with 34.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.36%
EPS Next 3Y34.69%

More info and screens

0

5. Dividend

5.1 Amount

CTRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURI HOLDINGS INC

NYSE:CTRI (2/21/2025, 8:11:16 PM)

After market: 18.63 0 (0%)

18.63

-1.06 (-5.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners25.06%
Inst Owner Change-85.35%
Ins Owners0.2%
Ins Owner Change0%
Market Cap1.65B
Analysts75.38
Price Target23.56 (26.46%)
Short Float %19.4%
Short Ratio8.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-46.34%
Min EPS beat(2)-80.47%
Max EPS beat(2)-12.2%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.24%
Min Revenue beat(2)-13.35%
Max Revenue beat(2)-7.13%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.6%
PT rev (3m)17.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)38.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.53%
Revenue NQ rev (1m)-1.95%
Revenue NQ rev (3m)-1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.97
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 3.13
P/tB N/A
EV/EBITDA 8.98
EPS(TTM)-2.15
EYN/A
EPS(NY)0.69
Fwd EY3.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.75
BVpS5.96
TBVpS-2.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.81%
ROE -35.31%
ROCE 7.9%
ROIC 6.21%
ROICexc 6.4%
ROICexgc 11.22%
OM 4.71%
PM (TTM) N/A
GM 9.43%
FCFM N/A
ROA(3y)-4.59%
ROA(5y)N/A
ROE(3y)-39.14%
ROE(5y)N/A
ROIC(3y)4%
ROIC(5y)N/A
ROICexc(3y)4.12%
ROICexc(5y)N/A
ROICexgc(3y)8.01%
ROICexgc(5y)N/A
ROCE(3y)5.1%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF N/A
Debt/EBITDA 3.21
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 2.24
F-ScoreN/A
WACC10.39%
ROIC/WACC0.6
Cap/Depr(3y)83.53%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y113.5%
EPS Next 2Y52.36%
EPS Next 3Y34.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-8.7%
Revenue Next 2Y-2.36%
Revenue Next 3Y0.26%
Revenue Next 5YN/A
EBIT growth 1Y80.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.75%
EBIT Next 3Y32.45%
EBIT Next 5YN/A
FCF growth 1Y273.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.98%
OCF growth 3YN/A
OCF growth 5YN/A